Postingan

As US Attorney, Labor Secretary Nominee Enabled Drug and Biotechnology Executives' Impunity

Petitions for Research Integrity and Against Corruption Available for Signature

Transparency International Reports on Massive Corruption in the Pharmaceutical Sector - Media Hardly Notices

Praluent, the Next Expensive "Game Changer," Blockbuster," "New Hope," - But Not Yet Shown to Benefit Patients

Entresto: Blockbuster, or Just Over Hyped? - Whatever, It Will Cost $4500 a Year

Minimizing Legal Liability or Upholding the Mission? - the Markingson Case Redux

Oh, the Prices we Pay ... for Questionable Drug Marketing to Enrich Corporate Insiders - the Case of Questcor's H P Acthar Revisited

Denying the Inconvenient Truth About Study 329